Short bowel syndrome is a serious condition that disrupts the body’s ability to absorb the nutrients and fluids needed for health. The main goals of treatment are to maintain proper nutrition, prevent dangerous complications, and help patients live fuller lives despite having less intestine than normal.

Finding the Right Path for Each Patient

When someone develops short bowel syndrome, their body faces a significant challenge. The shortened intestine cannot properly absorb the vitamins, minerals, fluids, and calories that the body needs to function normally. This creates a complex medical situation that requires careful, individualized care.^[1]

Treatment for short bowel syndrome is not one-size-fits-all. Each person’s approach depends on several factors, including how much intestine remains, which sections were removed or damaged, whether the colon is still present, and the individual’s age and overall health. Because of this complexity, managing short bowel syndrome requires coordination among multiple specialists working together as a team.^[2]

The overarching aim of all treatment approaches is to help the remaining intestine work as efficiently as possible while making sure the patient gets enough nutrition to stay healthy. For some people, this means long-term support through intravenous feeding. For others, the goal is to gradually reduce or eliminate the need for such support as the remaining bowel adapts over time.^[9]

Medical professionals now recognize that short bowel syndrome is a chronic condition requiring ongoing attention throughout a patient’s life. Treatment strategies include not only addressing immediate nutritional needs but also monitoring for complications that can develop years after the initial intestinal injury or surgery.^[13]

Standard Treatment Approaches

Nutritional support forms the foundation of short bowel syndrome treatment. Most patients require some form of specialized nutrition to prevent malnutrition and maintain healthy weight. This support takes different forms depending on how severe the condition is and which parts of the digestive system remain functional.^[10]

In the early phase after intestinal loss, called the acute stage, many patients need parenteral nutrition, which means receiving nutrients directly into a vein through an intravenous line. This bypasses the digestive system entirely and ensures the body gets essential calories, proteins, fats, vitamins, and minerals. Some patients also receive enteral nutrition, where liquid food is delivered through a tube placed into the stomach or small intestine. Even during this acute phase, doctors encourage patients to eat and drink small amounts by mouth when possible, as this helps the remaining intestine heal and begin adapting.^[10]

The body has a remarkable ability to compensate after intestinal loss through a process called intestinal adaptation. During this stage, which can last about two years in adults and even longer in children, the remaining intestine physically changes to absorb more nutrients and fluids. The intestinal walls may thicken, and the tiny finger-like projections that absorb nutrients can become longer. How well adaptation occurs depends on factors like the length of remaining intestine, which sections were removed, whether the colon is intact, and the presence of a valve called the ileocecal valve that normally regulates flow between the small and large intestine.^[10]

Dietary management is extremely important for short bowel syndrome patients. Rather than eating three large meals, patients typically need to eat six to eight small meals throughout the day. This helps maximize absorption by not overwhelming the shortened intestine with too much food at once. The types of foods recommended depend heavily on which intestinal segments remain. Complex carbohydrates like white bread, white pasta, white rice, and potatoes without skins are generally well tolerated and help provide energy. Protein sources such as meat, fish, eggs, and cheese are important for maintaining muscle and body function.^[11]

Foods to avoid typically include those high in insoluble fiber, such as raw vegetables, fruit skins, nuts, seeds, and whole grains, as these can increase intestinal output and reduce absorption. Concentrated sweets like candy, desserts, and fruit juices should be limited because they draw water into the intestine and worsen diarrhea. Foods artificially sweetened with sorbitol or mannitol should also be avoided for the same reason.^[15]

Staying properly hydrated presents a unique challenge. Simply drinking more water can actually make dehydration worse by increasing diarrhea or output from an ostomy (a surgically created opening). Instead, patients need special oral rehydration solutions that contain a precise ratio of salt, sugar, and water. This specific combination enhances fluid absorption across the intestinal wall, even when diarrhea is present. Patients are typically advised to sip these solutions slowly throughout the day, separate from meals, as drinking fluids with meals can speed up intestinal transit and reduce nutrient absorption.^[11]

Several medications play important roles in standard treatment. Antacids or medications that reduce stomach acid production help because less intestine means less ability to neutralize the normal acid produced by the stomach. Excess acid can damage the remaining intestine and worsen diarrhea. Antidiarrheal medications such as loperamide are often prescribed to be taken before meals to slow intestinal transit, giving the remaining bowel more time to absorb nutrients and fluids. Some patients need antibiotics to treat small intestinal bacterial overgrowth, a condition where bacteria multiply excessively in the shortened bowel and interfere with nutrient absorption.^[9]

Vitamin and mineral supplementation is essential for nearly all short bowel syndrome patients. Depending on which intestinal segments were removed, patients may have difficulty absorbing specific nutrients. For example, vitamin B12 and bile salts are absorbed in the last part of the small intestine called the terminal ileum, so patients missing this section need regular B12 injections. Fat-soluble vitamins (A, D, E, and K) are poorly absorbed when fat absorption is impaired. Minerals like calcium, magnesium, zinc, and iron often need supplementation because they are absorbed throughout the small intestine. Blood tests are performed regularly to monitor for deficiencies and adjust supplementation accordingly.^[13]

Surgical procedures may be part of standard treatment for some patients. Operations to slow the passage of food through the intestine give the remaining bowel more time to absorb nutrients. One procedure called autologous gastrointestinal reconstruction can actually lengthen the remaining intestine. For patients who cannot be weaned from parenteral nutrition despite optimal medical management, small bowel transplantation may be considered. This major operation involves replacing the damaged or insufficient intestine with a donated organ from a deceased donor.^[9]

The duration of treatment varies widely. Some patients eventually achieve independence from intravenous nutrition as their intestine adapts, which can take two years or longer. Others require lifelong parenteral nutrition support. Factors predicting the need for permanent nutritional support include having less than 50 to 70 centimeters of small intestine when the colon is present, or less than 100 to 150 centimeters when the colon is absent.^[20]

Potential complications from standard treatment include those related to parenteral nutrition itself. Long-term intravenous feeding can damage the liver, leading to parenteral nutrition-associated liver disease. Central venous catheters, which are needed to deliver parenteral nutrition, carry risks of infection and blood clots. Kidney stones are more common in short bowel syndrome patients due to altered absorption of certain substances. Metabolic bone disease can develop from poor absorption of calcium and vitamin D. Careful monitoring and preventive measures help reduce these complications.^[13]

Treatment in Clinical Trials

Research into new therapies for short bowel syndrome has brought significant advances in recent years, offering hope for patients who struggle with traditional treatments. Scientists have developed novel approaches that work differently from standard nutritional support and medications.^[6]

One of the most promising developments involves medications called glucagon-like peptide-2 analogues, or GLP-2 analogues. These drugs mimic a natural hormone in the body that stimulates intestinal growth and function. The most well-studied drug in this class is teduglutide, which has been tested extensively in clinical trials and has received regulatory approval in several countries.^[6]

Teduglutide works by promoting intestinal adaptation—the natural process where the remaining bowel becomes more efficient at absorbing nutrients and fluids. The medication does this by encouraging the intestinal lining to thicken, increasing the surface area available for absorption. It also slows gastric emptying and reduces stomach acid secretion, both of which help improve absorption. Clinical trials conducted in Phase III (the stage where new treatments are compared with standard care in larger patient groups) showed that teduglutide allowed more than half of treated patients to achieve at least a 30% reduction in their need for parenteral nutrition. Some patients were able to discontinue intravenous nutrition entirely. The medication is given as a daily injection under the skin.^[7]

Another medication studied in clinical trials is growth hormone, a natural hormone that promotes tissue growth throughout the body. When used in combination with a specialized oral diet and the amino acid glutamine, growth hormone has shown some ability to enhance intestinal adaptation in patients with short bowel syndrome. However, the results have been more variable than with GLP-2 analogues, and growth hormone has not been as widely adopted in clinical practice for this indication.^[6]

Clinical trials have also explored innovative surgical techniques beyond what is currently considered standard practice. Researchers are investigating methods to slow intestinal transit through novel surgical procedures, create better surgical reconstructions after massive intestinal loss, and improve outcomes for patients undergoing intestinal transplantation. These studies typically take place at specialized medical centers with extensive experience in managing complex intestinal failure.^[6]

Early-phase clinical trials (Phase I and Phase II, which focus on safety and preliminary effectiveness) are investigating other potential therapies. These include medications that affect intestinal hormone levels, drugs that modify the intestinal microbiome (the community of bacteria living in the gut), and substances that might enhance the natural healing and adaptation processes. While these approaches are still experimental, they represent the frontier of short bowel syndrome research and may lead to additional treatment options in the future.^[6]

Preliminary results from trials of various investigational therapies have shown encouraging signs. Besides achieving reductions in parenteral nutrition requirements, some studies have reported improvements in patient quality of life, fewer hospitalizations for complications, better hydration status, and positive safety profiles with manageable side effects. However, researchers emphasize that more data and longer follow-up periods are needed to fully understand the long-term benefits and risks of these emerging therapies.^[6]

The mechanism of action for many investigational therapies focuses on supporting the intestine’s natural ability to compensate after injury or resection. This approach, called pharmacologic bowel compensation, aims to enhance intestinal adaptation beyond what occurs naturally. By stimulating intestinal growth, improving the function of remaining intestinal cells, or altering the intestinal environment to favor better absorption, these therapies attempt to help patients achieve nutritional independence or at least reduce their reliance on parenteral support.^[6]

Patient eligibility for clinical trials varies by study but generally includes individuals with documented short bowel syndrome who remain dependent on parenteral nutrition despite optimal standard management. Some trials specifically focus on adults, while others include pediatric patients. Participants usually need to be medically stable without active infections or other serious health problems that might interfere with the study. The location of clinical trials can vary, with studies conducted at major medical centers in North America, Europe, and other regions around the world.^[9]

Most common treatment methods

• Parenteral Nutrition
  • Intravenous delivery of nutrients, fluids, vitamins, and minerals directly into the bloodstream
  • Bypasses the digestive system entirely when the intestine cannot absorb enough nutrients
  • May be required temporarily during the acute phase or long-term for patients who cannot achieve intestinal adaptation
  • Delivered through a central venous catheter, typically at home for long-term patients
• Enteral Nutrition
  • Liquid nutrition delivered through a feeding tube placed into the stomach or small intestine
  • Helps maintain intestinal function and promotes adaptation
  • May be used in combination with parenteral nutrition during the adaptation phase
• Specialized Diet Management
  • Small, frequent meals throughout the day to maximize nutrient absorption
  • Complex carbohydrates as primary energy source
  • Avoidance of concentrated sweets, high-fiber foods, and artificial sweeteners that worsen symptoms
  • Diet composition tailored to remaining intestinal anatomy
  • Use of oral rehydration solutions with specific salt and sugar ratios to maintain hydration
• Medications to Control Symptoms
  • Antidiarrheal agents like loperamide taken before meals to slow intestinal transit
  • Medications to reduce stomach acid production and protect remaining intestine
  • Antibiotics to treat small intestinal bacterial overgrowth when present
• Vitamin and Mineral Supplementation
  • Replacement of fat-soluble vitamins (A, D, E, K) when fat absorption is impaired
  • Vitamin B12 injections for patients missing the terminal ileum
  • Calcium, magnesium, zinc, and iron supplements as needed based on blood test results
  • Regular monitoring through blood tests to adjust supplementation
• Glucagon-Like Peptide-2 Analogues
  • Teduglutide, a medication that promotes intestinal adaptation and growth
  • Given as a daily injection under the skin
  • Can reduce or eliminate need for parenteral nutrition in some patients
  • Works by thickening intestinal lining and slowing gastric emptying
• Surgical Interventions
  • Procedures to slow intestinal transit and increase absorption time
  • Autologous gastrointestinal reconstruction to lengthen remaining intestine
  • Small bowel transplantation for patients with irreversible intestinal failure who cannot tolerate long-term parenteral nutrition